share_log

Raymond James Analysts Lower Earnings Estimates for Opsens Inc. (TSE:OPS)

Raymond James Analysts Lower Earnings Estimates for Opsens Inc. (TSE:OPS)

Raymond James分析师下调Opsens Inc.的收益预期(TSE:OPS)
Financial News Live ·  2022/07/20 02:51

Opsens Inc. (TSE:OPS – Get Rating) – Equities researchers at Raymond James dropped their FY2026 earnings estimates for Opsens in a note issued to investors on Thursday, July 14th. Raymond James analyst R. Sarugaser now anticipates that the company will post earnings of $0.09 per share for the year, down from their previous forecast of $0.10. The consensus estimate for Opsens' current full-year earnings is ($0.06) per share.

Opsens Inc.(TSE:OPS-GET Rating)-在7月14日星期四发布给投资者的一份报告中,Raymond James的股票研究人员下调了Opsens 2026财年的收益预期。Raymond James分析师R.Sarugaser现在预计,该公司今年的每股收益将为0.09美元,低于此前预测的0.10美元。对Opsens目前全年收益的普遍估计是每股0.06美元。

Get
到达
Opsens
奥普森斯
alerts:
警报:

Separately, Stifel Nicolaus began coverage on shares of Opsens in a research note on Wednesday, April 13th. They set a "buy" rating and a C$3.35 price objective for the company.

另外,Stifel Nicolaus在4月13日星期三的一份研究报告中开始报道Opsens的股票。他们为该公司设定了“买入”评级和3.35加元的目标价。

Opsens Stock Performance

奥普森股票表现

TSE OPS opened at C$2.35 on Monday. The company's 50 day moving average is C$2.13 and its 200-day moving average is C$2.09. Opsens has a 12-month low of C$1.55 and a 12-month high of C$3.74. The company has a quick ratio of 4.88, a current ratio of 5.87 and a debt-to-equity ratio of 18.46. The firm has a market cap of C$255.61 million and a P/E ratio of -39.83.
谢霆锋OPS周一开盘报2.35加元。该公司的50日移动均线切入位在2.13加元,200日移动均线切入位在2.09加元。Opsens的12个月低点为1.55加元,12个月高位为3.74加元。该公司的速动比率为4.88,流动比率为5.87,债务权益比为18.46。该公司市值为2.5561亿加元,市盈率为-39.83倍。

About Opsens

关于奥普森

(Get Rating)

(获取评级)

Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology.

Opsens Inc.开发、制造、安装和销售用于介入心脏病学、部分血流储备(FFR)、石油和天然气以及工业应用的光纤传感器。该公司在医疗和工业两个领域开展业务。医疗部门主要专注于生理测量,如冠状动脉狭窄市场的FFR和DPR;并提供一系列微型光学传感器,用于测量其他医疗设备中的集成应用中的压力和温度,并获得其光学传感器技术的许可。

Featured Stories

专题报道

  • Is There Finally Green Ahead for These 2 Cannabis Leaders?
  • Ford Races Higher: Has The Stock Finally Bottomed?
  • A Dose of AbbVie Stock Can Help Your Bear Market Portfolio
  • PayPal Stock is Attempting to Put in the Floor
  • These Consumer Stocks Will Thrive And Here's Why
  • 这两位大麻领头羊的未来最终会是绿色的吗?
  • 福特跑得更高:股价终于触底了吗?
  • 一剂艾伯维股票可以帮助你的熊市投资组合
  • 贝宝股票正试图在地板上
  • 这些消费类股将蓬勃发展,原因如下

Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.

接受Opsens Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Opsens和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发